Zoetis Inc. (BVMF:Z1TS34)
40.32
-1.94 (-4.59%)
At close: Nov 12, 2025
Zoetis Revenue
Zoetis had revenue of $2.40B USD in the quarter ending September 30, 2025, with 0.50% growth. This brings the company's revenue in the last twelve months to $9.40B, up 2.68% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.40B
Revenue Growth
+2.68%
P/S Ratio
5.65
Revenue / Employee
$680.94K
Employees
13,800
Market Cap
282.98B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
| Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
| Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
| Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
| Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 13.93B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |
| Odontoprev | 2.53B |